bf/NASDAQ:UBX_icon.jpeg

COM:UNITYBIOTECHNOLOGY

Unity Biotechnology

  • Stock

Last Close

1.17

21/11 21:00

Market Cap

24.34M

Beta: -

Volume Today

51.60K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-30.40M
-
-44.66M
46.88%
-76.40M
71.08%
-82.18M
7.56%
-93.84M
14.20%
-60.73M
35.29%
-59.93M
1.31%
-39.86M
33.49%
depreciation and amortization
153K
-
1.30M
752.29%
2.18M
67.18%
2.66M
22.16%
3.45M
29.52%
2.88M
16.50%
2.18M
24.31%
1.18M
45.78%
deferred income tax
8.97M
-
-408K
104.55%
-1.51M
271.32%
-6.93M
357.62%
2.38M
134.37%
920K
61.39%
-10.19M
-
stock based compensation
224K
-
3.03M
1,254.46%
9.44M
211.17%
10.85M
14.95%
13.81M
27.29%
11.55M
16.36%
9.38M
18.82%
7.42M
20.90%
change in working capital
1.99M
-
2.32M
17.08%
5.13M
120.61%
3.56M
30.54%
-4.55M
227.89%
-631K
86.14%
-1.02M
61.97%
-4.39M
329.65%
accounts receivables
inventory
accounts payables
198K
-
1.20M
505.05%
2.23M
85.98%
-227K
110.19%
-2.64M
1,063.00%
-573K
78.30%
-194K
66.14%
-410K
111.34%
other working capital
1.79M
-
1.13M
36.99%
2.90M
157.46%
3.79M
30.67%
-1.91M
150.53%
-58K
96.97%
-828K
1,327.59%
-3.98M
380.80%
other non cash items
2.67M
-
44K
98.35%
4.54M
10,222.73%
-387K
108.52%
420K
208.53%
943K
124.52%
-1.64M
273.81%
7.19M
538.80%
net cash provided by operating activities
-16.40M
-
-38.36M
133.92%
-56.62M
47.62%
-72.42M
27.90%
-78.33M
8.16%
-45.06M
42.48%
-51.03M
13.25%
-38.65M
24.26%
investments in property plant and equipment
-2.24M
-
-1.69M
24.73%
-1.26M
25.16%
-1.59M
25.47%
-646K
59.27%
-195K
69.81%
-96K
50.77%
-11K
88.54%
acquisitions net
-69.54M
-
4.56M
106.56%
-39.51M
966.02%
378K
100.96%
115K
69.58%
purchases of investments
-500K
-
-134.47M
26,793%
-204.59M
52.15%
-119.27M
41.70%
-138.49M
16.11%
-81.49M
41.16%
-98.83M
21.27%
-28.61M
71.05%
sales maturities of investments
49.85M
-
133.64M
168.10%
188.81M
41.28%
133.92M
29.07%
121M
9.65%
74M
38.84%
89M
20.27%
other investing activites
69.54M
-
-4.56M
106.56%
39.51M
966.02%
net cash used for investing activites
-2.74M
-
-86.31M
3,045.23%
-72.21M
16.34%
67.95M
194.11%
-5.21M
107.66%
39.31M
854.86%
-24.55M
162.43%
60.49M
346.47%
debt repayment
-55K
-
-74K
34.55%
-73K
1.35%
-405K
454.79%
-68K
83.21%
-3.18K
95.33%
-20M
629,028.66%
common stock issued
79.06M
-
26.09M
67.00%
37.27M
42.88%
18.57M
50.17%
54.71M
194.60%
5.22M
90.45%
common stock repurchased
-37K
-
400K
1,181.08%
27K
93.25%
dividends paid
-60.75M
-
-27K
99.96%
other financing activites
107.94M
-
42.87M
60.29%
118.30M
175.97%
1.43M
98.79%
27.01M
1,794.11%
2.34M
91.33%
145.18K
93.80%
-1.56M
1,176.60%
net cash used provided by financing activities
107.94M
-
42.77M
60.37%
136.93M
220.12%
27.44M
79.96%
63.88M
132.80%
20.84M
67.37%
54.85M
163.16%
-14.78M
126.94%
effect of forex changes on cash
net change in cash
88.80M
-
-81.89M
192.22%
8.10M
109.89%
22.97M
183.55%
-19.67M
185.62%
15.10M
176.77%
-20.72M
237.23%
7.07M
134.11%
cash at beginning of period
940K
-
89.74M
9,446.38%
7.85M
91.25%
15.95M
103.22%
38.92M
144.02%
19.25M
50.53%
34.35M
78.42%
12.74M
62.92%
cash at end of period
89.74M
-
7.85M
91.25%
15.95M
103.22%
38.92M
144.02%
19.25M
50.53%
34.35M
78.42%
13.63M
60.32%
19.80M
45.27%
operating cash flow
-16.40M
-
-38.36M
133.92%
-56.62M
47.62%
-72.42M
27.90%
-78.33M
8.16%
-45.06M
42.48%
-51.03M
13.25%
-38.65M
24.26%
capital expenditure
-2.24M
-
-1.69M
24.73%
-1.26M
25.16%
-1.59M
25.47%
-646K
59.27%
-195K
69.81%
-96K
50.77%
-11K
88.54%
free cash flow
-18.64M
-
-40.05M
114.82%
-57.89M
44.55%
-74.01M
27.85%
-78.98M
6.72%
-45.26M
42.70%
-51.13M
12.97%
-38.66M
24.38%

All numbers in (except ratios and percentages)